Ronald Bukowski
Hematology & Oncology · Cleveland, OHNPI 1952365603
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $575,045 of the $594,055 with a category attached, or 96.8%. 9 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 42.3% of the total. Among hematology & oncology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $2788.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$251K
- Exelixis Inc.$111K
- Merck$101K
- Janssen Research & Development, LLC$69K
- Pfizer$25K
- Eisai Inc.$17K
- plus $20K from 3 others
Across 2 payments — averaging $1107.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- QED Therapeutics, Inc.$2K
What the payments were for
- Consulting fees$575,04597%
- Speaking & faculty fees$12,3752%
- Travel & lodging$6,1621%
- Food & beverage$4730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 87 | $251,437 |
| Exelixis Inc. | 26 | $110,625 |
| Merck | 37 | $100,783 |
| Janssen Research & Development, LLC | 20 | $68,925 |
| Pfizer | 12 | $25,100 |
| Eisai Inc. | 28 | $17,036 |
| Acrotech Biopharma Inc. | 1 | $10,500 |
| AstraZeneca | 1 | $6,050 |
| GSK | 1 | $3,600 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$594,055 in reported general payments places this provider in the 95th percentile of 450 hematology & oncology providers in Ohio.
Other hematology & oncology in Cleveland
- Hillard LazarusCleveland$2M
- Balazs HalmosCleveland$568K
- Jorge GarciaCleveland$513K
- Bachar DerghamCleveland$387K
- Brian HillCleveland$316K
- Dale ShepardCleveland$314K
- Sakti ChakrabartiCleveland$301K
- Keith McCraeCleveland$215K
- Megan KruseCleveland$166K
- Afshin DowlatiCleveland$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.